Dacarbazine: Difference between revisions
Jump to navigation
Jump to search
imported>Howard C. Berkowitz No edit summary |
mNo edit summary |
||
| Line 1: | Line 1: | ||
{{subpages}} | {{subpages}} | ||
'''Dacarbazine''' is an [[antineoplastic agent]] considered a miscellaneous antialkylating agent, used for [[melanoma]] and in the [[ABVD]] combination therapy for [[Hodgkin's disease]]. Chemicall, it is 5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide. | '''Dacarbazine''' is an [[antineoplastic agent]] considered a miscellaneous antialkylating agent, used for [[melanoma]] and in the [[ABVD]] combination therapy for [[Hodgkin's disease]]. Chemicall, it is 5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide.[[Category:Suggestion Bot Tag]] | ||
Latest revision as of 11:00, 4 August 2024
Dacarbazine is an antineoplastic agent considered a miscellaneous antialkylating agent, used for melanoma and in the ABVD combination therapy for Hodgkin's disease. Chemicall, it is 5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide.